Bearing Point Capital LLC Buys Shares of 33,326 Danaher Co. (NYSE:DHR)

Bearing Point Capital LLC bought a new stake in Danaher Co. (NYSE:DHR - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 33,326 shares of the conglomerate's stock, valued at approximately $7,650,000. Danaher comprises 1.6% of Bearing Point Capital LLC's investment portfolio, making the stock its 19th biggest position.

Several other large investors have also modified their holdings of DHR. Vanguard Group Inc. lifted its holdings in shares of Danaher by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 59,750,122 shares of the conglomerate's stock valued at $13,715,641,000 after buying an additional 315,912 shares during the period. Geode Capital Management LLC lifted its holdings in Danaher by 2.4% in the fourth quarter. Geode Capital Management LLC now owns 13,358,206 shares of the conglomerate's stock valued at $3,056,996,000 after acquiring an additional 315,446 shares during the period. Norges Bank purchased a new stake in shares of Danaher during the 4th quarter worth $2,130,740,000. Bank of New York Mellon Corp grew its stake in shares of Danaher by 5.4% during the 4th quarter. Bank of New York Mellon Corp now owns 8,589,019 shares of the conglomerate's stock worth $1,971,609,000 after purchasing an additional 441,012 shares during the period. Finally, Northern Trust Corp increased its holdings in shares of Danaher by 14.3% in the 4th quarter. Northern Trust Corp now owns 7,934,991 shares of the conglomerate's stock valued at $1,821,477,000 after purchasing an additional 992,594 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.

Danaher Trading Down 3.7 %

Shares of Danaher stock traded down $7.29 during trading hours on Tuesday, hitting $190.11. The company's stock had a trading volume of 3,826,473 shares, compared to its average volume of 3,378,475. The business has a fifty day moving average of $199.23 and a 200 day moving average of $220.68. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. Danaher Co. has a 1-year low of $171.00 and a 1-year high of $281.70. The company has a market capitalization of $136.06 billion, a PE ratio of 36.01, a P/E/G ratio of 2.66 and a beta of 0.80.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.26. The company had revenue of $5.74 billion during the quarter, compared to the consensus estimate of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. As a group, equities analysts forecast that Danaher Co. will post 7.63 EPS for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.67%. Danaher's dividend payout ratio (DPR) is 24.85%.

Analyst Ratings Changes

DHR has been the topic of several recent analyst reports. Jefferies Financial Group lowered their target price on shares of Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a research report on Tuesday, April 22nd. Wells Fargo & Company dropped their price objective on Danaher from $280.00 to $240.00 and set an "equal weight" rating for the company in a research note on Thursday, January 30th. Royal Bank of Canada reissued an "outperform" rating and issued a $250.00 target price on shares of Danaher in a report on Wednesday, April 23rd. Stifel Nicolaus raised shares of Danaher from a "hold" rating to a "buy" rating and set a $260.00 price target on the stock in a report on Friday, March 14th. Finally, UBS Group decreased their price target on shares of Danaher from $275.00 to $240.00 and set a "buy" rating on the stock in a research note on Wednesday, April 23rd. Five investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat.com, Danaher currently has a consensus rating of "Moderate Buy" and a consensus price target of $264.40.

Insider Activity at Danaher

In other news, EVP Christopher Paul Riley sold 15,805 shares of the business's stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the sale, the executive vice president now owns 15,179 shares of the company's stock, valued at approximately $3,005,442. The trade was a 51.01 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 11.10% of the stock is currently owned by company insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.